This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, J. M.
Right arrow Articles by Song, I. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, J. M.
Right arrow Articles by Song, I. S.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2004, p. 4843-4847, Vol. 48, No. 12
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.12.4843-4847.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Distribution of Antibiotic MICs for Helicobacter pylori Strains over a 16-Year Period in Patients from Seoul, South Korea

Jung Mogg Kim,1 Joo Sung Kim,2 Hyun Chae Jung,2* Nayoung Kim,2 Young-Jeon Kim,3 and In Sung Song2

Department of Microbiology and Institute of Biomedical Science, College of Medicine, Hanyang University,1 Department of Internal Medicine and Liver Research Institute, College of Medicine, Seoul National University, Seoul,2 Department of Biotechnology, Joongbu University, Choongnam, South Korea3

Received 29 December 2003/ Returned for modification 21 March 2004/ Accepted 28 August 2004

Recently, the development of antibiotic resistance emerged as a significant clinical problem in the eradication of Helicobacter pylori. We investigated the MICs of antibiotics for 135 H. pylori isolates from adults in Seoul, South Korea, over the past 16 years. The MICs of amoxicillin, clarithromycin, metronidazole, tetracycline, azithromycin, and ciprofloxacin increased from 1987 to 2003. Rates of primary resistance to clarithromycin increased from 2.8% in 1994 to 13.8% in 2003. The A2144G mutation was frequently observed in the 23S rRNA gene in clarithromycin-resistant isolates. The increase in resistance to clarithromycin seems to result in a decrease in eradication efficacy for H. pylori. These results suggest that the MICs of several antibiotics for H. pylori have increased over the past 16 years in Seoul.


* Corresponding author. Mailing address: Department of Internal Medicine, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul 110-744, South Korea. Phone: 82-2-760-3344. Fax: 82-2-743-6701. E-mail: hyunchae{at}plaza.snu.ac.kr.


Antimicrobial Agents and Chemotherapy, December 2004, p. 4843-4847, Vol. 48, No. 12
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.12.4843-4847.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Xuan, S.-H., Zhou, Y.-G., Shao, B., Cui, Y.-L., Li, J., Yin, H.-B., Song, X.-P., Cong, H., Jing, F.-X., Jin, Q.-H., Wang, H.-M., Zhou, J. (2009). Enzymic colorimetry-based DNA chip: a rapid and accurate assay for detecting mutations for clarithromycin resistance in the 23S rRNA gene of Helicobacter pylori. J Med Microbiol 58: 1443-1448 [Abstract] [Full Text]  
  • Chisholm, S. A., Owen, R. J. (2009). Frequency and molecular characteristics of ciprofloxacin- and rifampicin-resistant Helicobacter pylori from gastric infections in the UK. J Med Microbiol 58: 1322-1328 [Abstract] [Full Text]  
  • Rimbara, E., Noguchi, N., Kawai, T., Sasatsu, M. (2008). Novel Mutation in 23S rRNA That Confers Low-Level Resistance to Clarithromycin in Helicobacter pylori. Antimicrob. Agents Chemother. 52: 3465-3466 [Full Text]  
  • Kim, J. M., Kim, J. S., Kim, N., Jung, H. C., Song, I. S. (2005). Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients. J Antimicrob Chemother 56: 965-967 [Abstract] [Full Text]